Wang M - Search Results

1

Circadian clock pathway genes associated with colorectal cancer risk and prognosis.

Gu D, Li S, Ben S, Du M, Chu H, Zhang Z, Wang M, Zhang ZF, Chen J. Gu D, et al. Among authors: wang m. Arch Toxicol. 2018 Aug;92(8):2681-2689. doi: 10.1007/s00204-018-2251-7. Epub 2018 Jul 2. Arch Toxicol. 2018. PMID: 29968159

2

A novel variable number of tandem repeats (VNTR) polymorphism containing Sp1 binding elements in the promoter of XRCC5 is a risk factor for human bladder cancer.

Wang S, Wang M, Yin S, Fu G, Li C, Chen R, Li A, Zhou J, Zhang Z, Liu Q. Wang S, et al. Among authors: wang m. Mutat Res. 2008 Feb 1;638(1-2):26-36. doi: 10.1016/j.mrfmmm.2007.08.011. Epub 2007 Aug 26. Mutat Res. 2008. PMID: 17904587

3

A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.

Wang M, Zhang Z, Zhu H, Fu G, Wang S, Wu D, Zhou J, Wei Q, Zhang Z. Wang M, et al. Among authors: wang s. Clin Cancer Res. 2008 Jun 1;14(11):3633-40. doi: 10.1158/1078-0432.CCR-07-5155. Clin Cancer Res. 2008. PMID: 18519798

4

Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.

Zhang Z, Wang S, Wang M, Tong N, Fu G, Zhang Z. Zhang Z, et al. Among authors: wang m, wang s. Carcinogenesis. 2008 Oct;29(10):1973-8. doi: 10.1093/carcin/bgn183. Epub 2008 Aug 5. Carcinogenesis. 2008. PMID: 18684727

5

Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis.

Wang M, Zhu H, Fu G, Wang M, Zhang Z, Lu Q, Wang S, Zhang Z. Wang M, et al. Among authors: wang s. Clin Exp Med. 2009 Mar;9(1):9-19. doi: 10.1007/s10238-008-0013-1. Epub 2008 Sep 25. Clin Exp Med. 2009. PMID: 18815869

6

Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.

Wang M, Wang M, Cheng G, Zhang Z, Fu G, Zhang Z. Wang M, et al. Mutat Res. 2009 Feb 10;661(1-2):85-92. doi: 10.1016/j.mrfmmm.2008.11.009. Epub 2008 Nov 25. Mutat Res. 2009. PMID: 19070628

7

FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies.

Zhang Z, Xue H, Gong W, Wang M, Yuan L, Han S, Zhang Z. Zhang Z, et al. Among authors: wang m. Carcinogenesis. 2009 Mar;30(3):487-93. doi: 10.1093/carcin/bgp016. Epub 2009 Jan 23. Carcinogenesis. 2009. PMID: 19168581

8

A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer.

Wang M, Zhang Z, Tian Y, Shao J, Zhang Z. Wang M, et al. Clin Cancer Res. 2009 Apr 1;15(7):2567-72. doi: 10.1158/1078-0432.CCR-08-2829. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276244

9

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.

Zhang Z, Qiu L, Wang M, Tong N, Li J, Zhang Z. Zhang Z, et al. Among authors: wang m. Eur J Hum Genet. 2009 Oct;17(10):1294-303. doi: 10.1038/ejhg.2009.45. Epub 2009 Apr 1. Eur J Hum Genet. 2009. PMID: 19337311 Free PMC article.

10

Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population.

Wang M, Wang M, Zhang W, Yuan L, Fu G, Wei Q, Zhang Z. Wang M, et al. Carcinogenesis. 2009 Jun;30(6):991-6. doi: 10.1093/carcin/bgp091. Epub 2009 Apr 15. Carcinogenesis. 2009. PMID: 19369583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67,986 results

Search Page

Filters